Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyaluronic acid in progressive systemic sclerosis

J P Freitas1, P Filipe, I Emerit

  • 1Department of Dermatology, Hospital of Santa Maria, Lisbon, Portugal.

Dermatology (Basel, Switzerland)
|January 1, 1996
PubMed
Summary

Elevated hyaluronic acid (HA) levels in progressive systemic sclerosis (PSS) patients correlate with disease severity and visceral organ involvement, particularly lung compromise. This suggests HA may serve as a key serologic marker for PSS progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Evidence on the Effectiveness and Safety of Spesolimab in the Treatment of Generalized Pustular Psoriasis Flares: A Case Series.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025
Same author

Subungual Exostosis of the Second Finger.

Actas dermo-sifiliograficas·2024
Same author

Phototherapy in the artificial intelligence era.

Photodermatology, photoimmunology & photomedicine·2023
Same author

Subungual Exostosis of the Second Finger.

Actas dermo-sifiliograficas·2023
Same author

Exuberant cutaneous metastasis of gastric adenocarcinoma.

Actas dermo-sifiliograficas·2023
Same author

Reply to: 'Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab' by Baffa et al.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Area of Science:

  • Biochemistry
  • Rheumatology
  • Immunology

Background:

  • Glycosaminoglycan metabolism is altered in progressive systemic sclerosis (PSS).
  • Elevated serum hyaluronic acid (HA) is a known characteristic of PSS.

Purpose of the Study:

  • To investigate plasma hyaluronic acid (HA) concentrations in PSS patients across different disease stages.
  • To correlate HA levels with the extent of organ involvement in PSS.

Main Methods:

  • Studied 48 PSS patients categorized into three subgroups based on organ involvement (skin only, skin/esophagus, skin/lung/other organs).
  • Quantified plasma HA levels using a radiometric assay.

Main Results:

  • Confirmed significantly elevated plasma HA levels in PSS patients compared to healthy individuals (p <0.001).

Related Experiment Videos

  • Observed significant differences in HA levels between patient subgroups, with the highest levels in those with lung and other organ involvement (p <0.01).
  • Demonstrated a positive correlation between disease severity scores and plasma HA concentrations (p <0.01), indicating lung involvement as a key factor.

    • Conclusions:

    • Elevated plasma HA levels in PSS patients may act as a serologic marker for disease severity.
    • Plasma HA levels can indicate the degree of visceral involvement in PSS.
    • HA elevation is linked to disease progression and severity in PSS.